A carregar...

Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study

BACKGROUND: Limited prospective data are available on the long-term safety of darbepoetin alfa (DA) for treating anemia in children with chronic kidney disease (CKD). METHODS: In this prospective, phase IV, observational registry study, children ≤16 years of age with CKD anemia and receiving DA were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Nephrol
Main Authors: Schaefer, Franz, Hoppe, Bernd, Jungraithmayr, Therese, Klaus, Günter, Pape, Lars, Farouk, Mourad, Addison, Janet, Manamley, Nick, Vondrak, Karel
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4756039/
https://ncbi.nlm.nih.gov/pubmed/26482252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-015-3225-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!